Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant FOLFOX in high-risk HCC after resection
NCT02738697Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2016
- Primary completion
- Dec 2020
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, folinic acid, fluorouracil in hepatocellular carcinoma (HCC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
oxaliplatinfolinic acidfluorouracil
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02738697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02738697.